Table 1.
GRO-seq | PRO-seq | NET-seq | 3′NT | Human NET-seq | Mammalian NET-seq | |
---|---|---|---|---|---|---|
Nuclear run on | Yes | Yes | No | No | No | No |
RNA fragmentation | Alkaline hydrolysis | Alkaline hydrolysis | Alkaline hydrolysis | Alkaline hydrolysis | Alkaline hydrolysis | MNase digestion |
RNA selection | BrU antibody | Biotin-streptavidin | FLAG antibody | 5′ cap antibody | No selection | Endogenous Pol II antibody |
Pol II modification analyses | No | No | No | No | No | Yes |
RNA processing analyses | No | No | No | No | No | Yes (splicing and miRNA processing) |
Resolution | 30–100 bases | 1 base | 1 base | 1 base | 1 base | 1 base |
Tested species | Human20, mouse21, Drosophila22 and Caenorhabditis elegans23 | Human24 and Drosophila8 | Yeast11 and Bacteria12 | Drosophila9 | Human10 | Human13 |
mNET-seq is the only currently available method that allows analysis of both Pol II pausing and co-transcriptional RNA processing at single-nucleotide resolution in a CTD phosphorylation–specific manner.